A61K 35/39
Pancreas
Official title: Pancreas; Islets of Langerhans (Langerhans cells of epidermis A61K35/36)
A61K35/39 (Pancreas) appears on 524 US grants and 964 published applications in this corpus.
Search patents in A61K- Granted patents
- 524
- Published applications
- 964
- Assignees
- 375
- Inventors
- 1,357
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 8 | 0 |
| 1998 | 19 | 0 |
| 1999 | 16 | 0 |
| 2000 | 4 | 0 |
| 2001 | 1 | 2 |
| 2002 | 4 | 5 |
| 2003 | 3 | 5 |
| 2004 | 2 | 13 |
| 2005 | 1 | 11 |
| 2006 | 6 | 14 |
| 2007 | 2 | 16 |
| 2008 | 5 | 16 |
| 2009 | 2 | 20 |
| 2010 | 5 | 24 |
| 2011 | 5 | 24 |
| 2012 | 7 | 24 |
| 2013 | 10 | 31 |
| 2014 | 18 | 42 |
| 2015 | 21 | 50 |
| 2016 | 24 | 68 |
| 2017 | 29 | 65 |
| 2018 | 34 | 54 |
| 2019 | 40 | 65 |
| 2020 | 39 | 57 |
| 2021 | 42 | 68 |
| 2022 | 34 | 66 |
| 2023 | 29 | 62 |
| 2024 | 34 | 65 |
| 2025 | 29 | 43 |
| 2026 | 32 | 54 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Neo-Islets comprising stem and islet cells and treatment of diabetes mellitus therewith6 Oct 2026US 12,753,392 B2SymbioCellTech, LLC
- Methods for reducing elevated glucose levels11 Aug 2026US 12,703,856 B2SDF BioPharma Inc.
- Methods and compositions for treatment of type 1 diabetes using fibroblasts as facilitators of islet engraftment28 Jul 2026US 12,691,147 B2Fibrobiologics, Inc.
- Formulations for pancreatic islet encapsulation21 Jul 2026US 12,685,711 B2Wake Forest University Health Sciences
- Generation of pancreatic endoderm from stem cell derived definitive endoderm21 Jul 2026US 12,686,855 B2Aspect Biosystems Ltd.
- Compositions and methods for propogating insulin and glucagon secreting cells from type 1 diabetic pancreatic tissue and therapeutic uses thereof8 Oct 2026US 2026/0308529 A1Imagine Pharma LLC
- Compositions and methods for propagating insulin- producing islet cells and therapeutic uses thereof cross reference to related applications8 Oct 2026US 2026/0308530 A1Imagine Pharma LLC
- Liquid for preservation or transplantation of encapsulated islet1 Oct 2026US 2026/0294980 A1Otsuka Pharmaceutical Factory, Inc.
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- Ribosomal Remodeling in Diabetes1 Oct 2026US 2026/0295074 A1Joslin Diabetes Center, Inc.
Most cited
By later US patents
- Encapsulation of biological material667US 4,352,883 ADamon Corporation · 1982
- Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products448US 6,083,523 ABrown University · 2000
- Microcapsules containing viable tissue cells318US 4,391,909 ADamon Corporation · 1983
- In vitro growth of functional islets of Langerhans and in vivo uses thereof169US 6,001,647 AIxion Biotechnology, Inc. · 1999
- Endoderm cells from human embryonic stem cells169US 7,326,572 B2Geron Corporation · 2008